Sort   by:  
 Page size 
UnknownEvaluation of short-course durvalumab combined with dose-dense EC in the neoadjuvant setting for locally advanced luminal B/HER2(-) or triple-negative breast cancer.
Not available
S-EPMC12661675 | biostudies-literature
UnknownA phase IV prospective study of efficacy and safety of ribociclib and letrozole as first-line therapy in older women (≥70 years) with hormone receptor-positive HER2-negative advanced breast cancer: the RibOB study.
Not available
S-EPMC12816914 | biostudies-literature
UnknownDarolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Not available
S-EPMC9844551 | biostudies-literature
Sort   by:  
 Page size